Home  >  Products  >  Igf2bp1 (insulin-like growth factor 2 mRNA binding protein 1 ) Blocking Peptide (the N terminal of Igf2bp1)(100ug)
Igf2bp1 (insulin-like growth factor 2 mRNA binding protein 1 ) Blocking Peptide (the N terminal of Igf2bp1)(100ug)

Igf2bp1 (insulin-like growth factor 2 mRNA binding protein 1 ) Blocking Peptide (the N terminal of Igf2bp1)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-Igf2bp1 Antibody (ARP58385_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human, Mouse
Presku: AAP58385
Size: 100ug
Weight: 63kDa
Gene: The peptide is characterized by mass spectroscopy
Format: Lyophilized powder
Target: Igf2bp1 is a RNA-binding factor that affects mRNA nuclear export, localization, stability and translation.
Alternative names: AL024068; AW549074; CRD-BP; Crdbp; D030026A21Rik; D11Moh40e; D11Moh45; IMP-1; Neilsen; Zbp1
See Full Product Listings >